4//SEC Filing
VAN VOORHEES SETH 4
Accession 0001415889-22-011778
CIK 0001719406other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 7:42 AM ET
Size
7.7 KB
Accession
0001415889-22-011778
Insider Transaction Report
Form 4
VAN VOORHEES SETH
Chief Financial Officer
Transactions
- Purchase
Common Stock, par value $0.001 per share
2022-11-25$1.10/sh+600$660→ 9,316 total(indirect: By 401(k)) - Purchase
Common Stock, par value $0.001 per share
2022-11-25$1.11/sh+7,021$7,793→ 16,377 total(indirect: By 401(k)) - Purchase
Common Stock, par value $0.001 per share
2022-11-25$1.12/sh+8,716$9,762→ 8,716 total(indirect: By 401(k))
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
Related Parties
1- filerCIK 0001284934
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 7:42 AM ET
- Size
- 7.7 KB